AzTrials
AzTrials

PreeclampsiapreeclamsideNCT06730048

The Effect of Augmented Reality Based Training on Preeclampsia Case

A study testing Experimental Group in people with Preeclampsia and Nursing Care, run by Inonu University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

However, no study has been found in the care of preeclampsia, which is highly effective on maternal and fetal health. Therefore, this study was planned to determine the effect of augmented reality-based training on the diagnosis and intervention planning skills of nursing students. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Preeclampsia, Nursing Care, Pregnancy
What is being tested?
Experimental Group
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
84 participants
Where
1 siteTurkey (Türkiye)
Study dates
20 Dec 2024to 20 Aug 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Continuing the course of Women's Health and Diseases Nursing,
  • Volunteering to participate in the research,
  • No physical or psychological health problems preventing the completion of the research forms.

Who cannot join

  • - Not watching the whole case given with virtual glasses,
  • Failure to attend class during the week of the preeclampsia lecture in the course syllabus.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

simge öztürk, Ph.D contact

05398751788

sozturk@bartin.edu.tr

Turkey (Türkiye)1 site
  • Inonu University

    Malatya, 44200

    simge öztürk, Ph.D, 05398751788, sozturk@bartin.edu.tr

    sermin timur taşhan, Ph.D

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Augmented Reality Based Training on Preeclampsia Case on Nursing Students' Diagnosis and Intervention Planning Skills

However, no study has been found in the care of preeclampsia, which is highly effective on maternal and fetal health. Therefore, this study was planned to determine the effect of augmented reality-based training on the diagnosis and intervention planning skills of nursing students.

Read the detailed description

Although pregnancy is a physiological process in women's lives, many women lose their lives due to the lack of timely and appropriate treatment of the complications it brings with it. According to the World Health Organization 2024 report, approximately 800 women die every day due to preventable causes related to pregnancy and childbirth. Preeclampsia, which is among the hypertensive diseases of pregnancy, is a complication of pregnancy and ranks among the top three causes of maternal mortality worldwide. Preeclampsia is defined as hypertension that develops after the 20th week of pregnancy and is accompanied by proteinuria/thrombocytopenia, renal failure, liver dysfunction, and cerebral/visual symptoms.

Considering the risks of preeclampsia complications, taking precautions before the onset of complications and treating complications with appropriate methods are extremely important in reducing the mortality rates of both pregnant and fetus. In order to maintain safe patient care and the health of individuals, nurses should know what kind of nursing care should be applied in the antenatal period to diagnose, evaluate and prevent complications of preeclampsia. In the literature, it is recommended that nursing care for preeclampsia patients should include the diagnoses of infection risk, disruption in sleep pattern, acute pain, constipation, impaired physical movement, lack of self-care, and fatigue. Nursing care should include individualized, holistic, systematic, high quality, feasible, applicable, sustainable care methods including technological methods, models and theories for all pregnant women with more than 2 of the risks of preeclampsia by ACOG.

Technological methods, which have been frequently used in the health system in recent years, are used because they are cheap, usable, accelerate the decision-making process, and reduce workload. Virtual reality (VR) applications are technological applications that create a reality environment with the help of scenarios and facilitate learning complex cases and diseases by increasing students' knowledge and skills. In addition, this method allows students to develop critical thinking skills, participate in clinical decision-making processes and receive feedback. In the literature, VR application has been used in triage patients and nursing care of pediatric patients. However, no study has been found in the care of preeclampsia, which is highly effective on maternal and fetal health. Therefore, this study was planned to determine the effect of augmented reality-based training on the diagnosis and intervention planning skills of nursing students.

Being tested
Experimental Group, Control group (placebo)
Keywords
preeclampsia, nursing care, pregnancy, augmented reality
Medical subject headings
Pre-Eclampsia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Experimental GroupOther

    An appointment will be made to meet with the students in the experimental group in a suitable classroom of the school. After the pre-test data, the students in the experimental group will be shown the preeclampsia case with virtual glasses for about 5-10 minutes. Then the post-test will be applied. A scenario including preeclampsia case and nursing care practices will be created in the virtual reality environment, and 10 experts will be consulted about the scenario before the students are shown it. This application will not have any side effects.

  • Control group (placebo)Other

    After the pre-test data, the preeclampsia case will be explained to the students in the control group with the classical lecture method in the Women's Health and Diseases Nursing course and the post-test will be applied.

Study groups in NCT06730048
Study groupRoleWhat they receive
experimental groupExperimentalAn appointment will be made to meet with the students in the experimental group in a suitable classroom of the school. After the pre-test data, the students in the experimental group will be shown the preeclampsia case with virtual glasses for about 5-10 minutes. Then the post-test will be applied. A scenario including preeclampsia case and nursing care practices will be created in the virtual reality environment, and 10 experts will be consulted about the scenario before the students are shown it. This application will not have any side effects.
Receives: Other: Experimental Group
control groupOtherAfter the pre-test data, the preeclampsia case will be explained to the students in the control group with the classical lecture method in the Women's Health and Diseases Nursing course and the post-test will be applied.
Receives: Other: Control group (placebo)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Preeclampsia Nursing Care Plan

    he nursing care plan consists of 4 open-ended questions including nursing diagnosis, risks, interventions and evaluation. Students will receive 3 points for each correct diagnosis. If they write all of the diagnoses, they will receive a total of 48 points from the diagnoses. If they correctly write 2 of the risk factors related to the diagnosis of preeclampsia added to the diagnoses for each diagnosis, they will receive 1 point from each diagnosis. They will receive a maximum of 16 points from risks. If they write at least 5 nursing interventions for each diagnosis, they will receive 2 points for each diagnosis. A maximum of 32 points will be obtained from interventions. The evaluation part will be 0.25 points. If they write the evaluations of all diagnoses correctly, they will receive 4 points. A total of 100 points can be obtained from the nursing care plan, with a minimum of 0 and a maximum of 48+16+32+32+4.

    Measured: one month

Secondary outcomes (3)
  1. Participant Information Form

    The information form, which was created by utilizing the literature, consists of a total of 10 questions (student's name, surname, telephone number, student number, age, gender, pre-preparation information, etc.).

    Measured: one month

  2. Preeclampsia Knowledge Test

    The preeclampsia information form (preeclampsia symptoms, ric factors, laboratory findings of preeclampsia, etc.) created by the researchers in line with the literature consists of a total of 10 questions. Each question is evaluated as 1 point and a minimum score of 0 and a maximum score of 10 can be obtained from the test. Before finalizing the information form, the opinions of 10 experts will be taken to determine its suitability.

    Measured: one month

  3. Presence Scale

    The Turkish validity and reliability study of the scale developed by Witmer et al. (2005) was conducted by Gökoğlu and Çakıroğlu (2019). Consisting of 29 items, the five-point Likert-type scale has five sub-dimensions: Engagement, Adaptation/Environmentalization, Sensory Engagement, Interaction, and Interface Quality. High scores obtained from the scale indicate that presence is effective.

    Measured: one month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Dec 2024
  2. Study start20 Dec 2024 (estimated)
  3. Primary completion20 Feb 2025 (estimated)
  4. Study completion20 Aug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
two-group study, experimental and control group
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
84 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06730048
Sponsor's protocol ID
Inonu3
Acronym
preeclamside
Status last verified
Dec 2024
First submitted
8 Dec 2024
Last updated
12 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Experimental Group in people with Preeclampsia and Nursing Care, run by Inonu University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 12 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact simge öztürk, Ph.D (05398751788, sozturk@bartin.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Preeclampsia Nursing Care Plan (time frame: one month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Dec 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in